Want to see TSE:BRM full AI Analyst Report?
BRM Stock Chart & Stats
C$3.02
-C$0.01(-0.33%)
At close: 4:00 PM EDT
C$3.02
-C$0.01(-0.33%)
Day’s Range― - ―
52-Week RangeC$1.87 - C$3.95
Previous CloseN/A
Volume9.69K
Average Volume (3M)32.44K
Market Cap
C$59.68M
Enterprise ValueC$54.18
Total Cash (Recent Filing)C$7.19M
Total Debt (Recent Filing)C$2.49M
Price to Earnings (P/E)9.4
Beta0.46
Next Earnings
Nov 24, 2026EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.38
Shares Outstanding16,307,028
10 Day Avg. Volume30,537
30 Day Avg. Volume32,440
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)2.90
Price to Sales (P/S)1.02
P/FCF Ratio5.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.3
Revenue Forecast (FY)C$47.50M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthThe combination of sustained growth and accelerating TTM revenue indicates expanding project activity. If maintained, this can improve Biorem’s ability to fund development and compete for larger contracts.
Low LeverageThe sharp reduction in leverage lowers interest and refinancing exposure. Growing equity and assets provide flexibility to absorb project timing changes and invest in expansion without relying heavily on external debt.
Sustainable ProfitabilityHealthy operating, EBITDA, and net margins show that Biorem’s engineered solutions can generate meaningful profits. This cushion may support reinvestment and resilience as project volumes and customer mix fluctuate.
Bears Say
Weak Recent Cash ConversionWeak recent cash conversion suggests working-capital swings or higher investment needs are absorbing earnings. This could constrain funding for projects and expansion until operating and free cash flow recover.
Revenue And Margin VariabilityThe prior revenue decline and uneven gross margins indicate sensitivity to demand and project mix. Variable contract economics could make earnings less predictable and limit confidence in margin durability.
ROE Sustainability RiskVery high ROE is a strength, but its potential volatility creates a sustainability risk. A lower future return base could weaken Biorem’s efficiency advantage and reduce internally generated growth capacity.
Biorem Inc News
BRM FAQ
What was Biorem Inc’s price range in the past 12 months?
Biorem Inc lowest stock price was C$1.87 and its highest was C$3.95 in the past 12 months.
What is Biorem Inc’s market cap?
Biorem Inc’s market cap is C$59.68M.
When is Biorem Inc’s upcoming earnings report date?
Biorem Inc’s upcoming earnings report date is Nov 24, 2026 which is in 95 days.
How were Biorem Inc’s earnings last quarter?
Biorem Inc released its earnings results on Jul 28, 2026. The company reported C$0.105 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Biorem Inc overvalued?
According to Wall Street analysts Biorem Inc’s price is currently Overvalued.
Does Biorem Inc pay dividends?
Biorem Inc does not currently pay dividends.
What is Biorem Inc’s EPS estimate?
Biorem Inc’s EPS estimate is 0.09.
How many shares outstanding does Biorem Inc have?
Biorem Inc has 16,307,028 shares outstanding.
What happened to Biorem Inc’s price movement after its last earnings report?
Biorem Inc reported an EPS of C$0.105 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 18.482%.
Which hedge fund is a major shareholder of Biorem Inc?
Currently, no hedge funds are holding shares in TSE:BRM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Biorem Inc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.30%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
31.51%
Trailing 12-Months
Company Description
Biorem Inc
BioRem Inc. is a clean technology engineering firm specializing in the development, manufacturing, and global distribution of environmental air purification systems. These systems are engineered to combat a range of airborne contaminants, including foul smells, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). Their comprehensive product line features biofilters for treating odors, hydrogen sulfide (H2S), VOCs, and HAPs, alongside biotrickling filters specifically designed for high concentrations of H2S or water-soluble VOCs. The company also supplies advanced multi-stage systems for odor removal in municipal and urban wastewater treatment facilities, biogas desulfurization systems, dry scrubber adsorption systems, and solutions for cannabis odor control. Complementing its product offerings, BioRem provides essential services such as biological process testing, media sampling and analysis, system reviews and inspections, and the provision of replacement media and spare parts. With operations spanning Canada, the United States, China, and other international regions, BioRem Inc. was founded in 1990 and is based in Puslinch, Canada.
Technical Analysis
―
Sharc International Systems Inc
―
Questor Technology
―
Thermal Energy International
―
Greenlane Renewables Inc
―